Omeros OMER
NASDAQ OMER
$19.13 +0.02 (+0.10%)
As of: Sep 4, 2026 · 3:20 PM EDT

Omeros (OMER) Long-Term Investments (2015 - 2018)

Omeros (OMER) posted Long-Term Investments of $1.2 million for Q4 2018, down 80.22% sequentially from $5.8 million in Q4 2017, and down 80.22% YoY from $5.8 million in Q4 2017.

Analysis

Omeros (OMER) Long-Term Investments (2015 - 2018) Analysis & Trends

Omeros has reported Long-Term Investments for 4 years, with the latest figure at $1.2 million in Q4 2018.

  • Quarterly Long-Term Investments fell 80.22% year-over-year to $1.2 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $1.2 million (down 80.22% YoY) and the FY2018 annual result came in at $1.2 million, down 80.22% from the prior year.
  • Long-Term Investments eased to $1.2 million in Q4 2018 per OMER's latest filing, from $5.8 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $10.7 million in Q4 2015 and troughed at $1.2 million in Q4 2018.
  • A 4-year average of $5.9 million and a median of $5.8 million in 2016 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2017 and 2018: Long-Term Investments changed 0.0% in 2017, then slumped 80.22% in 2018.
  • Over 4 years, Long-Term Investments stood at $10.7 million in 2015, then slumped by 45.36% to $5.8 million in 2016, then changed by 0.0% to $5.8 million in 2017, then sank by 80.22% to $1.2 million in 2018.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $1.2 million, $5.8 million, and $5.8 million for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -4.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 372.10 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.15 Mn
Dec 31, 2017 5.84 Mn
Dec 31, 2016 5.84 Mn
Dec 31, 2015 10.68 Mn